Alert detail
FDA Approval: ZEVTERA (CEFTOBIPROLE MEDOCARIL SODIUM) — Type 1 - New Molecular Entity
Policy ID: FDA-NDA218275Specialty: Infectious DiseaseAdded: 7/1/2026Effective: 2024-04-03billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.